Redecke, Vanessa
Tawaratsumida, Kazuki
Larragoite, Erin T.
Williams, Elizabeth S. C. P.
Planelles, Vicente
Spivak, Adam M.
Hirayama, Lincoln
Elgort, Marc
Swenson, Shane
Smith, Rick
Worthen, Bryan
Zimmerman, Russ
Slev, Patricia
Cahoon, Ben
Astill, Mark
Häcker, Hans
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (AI145877, AI139014)
School of Medicine
Article History
Received: 13 July 2021
Accepted: 20 December 2021
First Online: 30 December 2021
Competing interests
: VR and HH serve as inventors on a patent by the University of Utah (related to the constructs). BC, BW, RS, RZ, and SS are shareholders in Techcyte. VR, HH, Techcyte and ARUP are co-founders and equity holders of NanoSpot.ai. KT, ETL, ESCPW, VP, AMS, LH, ME, PS and MA have no conflict of interests.